Back to Journals » Clinical Interventions in Aging » Volume 4
Primary treatment of diabetic macular edema
Published 25 February 2009 Volume 2009:4 Pages 101—107
DOI https://doi.org/10.2147/CIA.S4357
Review by Single anonymous peer review
Peer reviewer comments 2
Tushar M Ranchod, Stuart L Fine
Scheie Eye Institute, Department, of Ophthalmology, University of Pennsylvania, Philadelphia, PA, USA Abstract: Diabetic macular edema (DME) is a leading cause of vision loss in older Americans. Thermal laser treatment remains the mainstay of treatment for DME. Recently, alternative primary treatments for DME have been evaluated. These treatments include intravitreal injections of steroids as well as pharmaceuticals containing antibodies against vascular endothelial growth factor (VEGF). Surgical treatment has been shown to be appropriate in selected cases. We review the evidence and scientific rationale for various primary treatment options in patients with DME. Regular and timely ophthalmologic evaluation remains crucial to recognition and treatment of macular edema in diabetic patients.
Keywords: diabetic macular edema, vision loss, diabetes mellitus
© 2009 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.